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The thalamic reticular nucleus (TRN) filters somatosensory stimuli by providing inhibition to the 
excitatory thalamic relay nuclei, which then communicate with the cortex to appropriately 
integrate and respond to sensory stimuli. The TRN is also responsible for generating and 
maintaining sleep spindles, which are important for memory and cognition, and are disrupted in 
various psychiatric disorders. Previous studies have shown that the TRN is comprised of several 
neuronal subpopulations that carry out specific functions. These neurons can be distinguished 
using peptide markers such as parvalbumin (PV), somatostatin (SST), and calbindin (CB). In this 
thesis, I identified a novel neuronal population in the TRN that expresses the peptide 
cholecystokinin (CCK) and distal-less homeobox gene 5/6 (Dlx5/6). CCK;Dlx5/6 neurons have 
been widely studied in the hippocampus and amygdala where they have been shown to highly 
express the type 1 cannabinoid receptor (CB1R) and produce a long-lasting inhibition of pyramidal 
neurons. However, basic characterization of CCK;Dlx5/6 neurons has been missing. Through 
immunohistochemical assays, we found that CCK;Dlx5/6  neurons of the TRN express CB1R and 
the CCK peptide. Our results show that CCK;Dlx5/6 are highly concentrated in the dorsal areas of 
the TRN relative to the ventral ones, dorsal areas of the TRN are associated with processing of 
visual cues. Our preliminary results also show that dorsal and ventromedial areas of the thalamus 
receive more inputs from CCK;Dlx5/6 neurons than ventral and medial thalamic areas. 
Furthermore, some of the CCK;Dlx5/6 neurons establish perisomatic synapses with neurons of the 
lateral dorsal nucleus of the thalamus, this type of connectivity is consistent with previous 
observations for CCK neurons in amygdala and hippocampus. Taken together our results provide 







1.1 Sensory processing in both physiological and pathological conditions  
Sensory processing depends on the proper functioning of peripheral sensory receptors that 
transform environmental cues into electrical signals that can then be interpreted at the central level. 
Sensory information passes through the thalamus before reaching the cortex where they ultimately 
lead to a response (Sherman & Guillery, 2002). Sensory processing is the foundation for selective 
attention and the proper perception of reality, which depends on a balance of excitation and 
inhibition within the brain as too much excitation and/or too little inhibition can lead to the 
perception of non-salient stimuli (Foss-Feig et al., 2017; Zheng, Matsuo, Miyamoto, & Hoshino, 
2014). The inability to properly process sensory information, whether that be hypersensitivity or 
hyposensitivity, is at the core of many neurological and neurodevelopmental disorders and is 
thought to be a consequence of excitation-inhibition imbalance (Kang et al., 2019;Rubenstein & 
Merzenich, 2003; Foss-Feig et al., 2017). 
Attention deficit disorder with or without hyperactivity (ADD and ADHD) are defined by 
cognitive rigidity, impulsivity, and inattention according the American Psychological Association 
(American Psychiatric Association, 2013). Children with ADHD often suffer from comorbid 
autism spectrum disorders (ASD) (Naaijen et al., 2017), which are largely characterized by having 
deficits with social communication and the presence of repetitive behaviors (American Psychiatric 
Association, 2013 ). Another common symptom of ASD is sensory over-responsivity, which is 
associated with higher severity of social and repetitive behaviors (Ben-Sasson et al., 2008; Green 
et al., 2018). Attention deficits and disrupted sensory processing seen in ADHD and ASD are also 
common in patients with schizophrenia (McGhie & Chapman, 1961;Krol et al., 2018). 




categories: positive and negative symptoms. Positive symptoms include hallucinations, delusions, 
and disorganized thoughts while negative symptoms refer to anhedonia, impaired social behavior, 
and lack of emotional expression (Curley & Lewis, 2012). Cognitive processes such as working 
memory are also dramatically impaired in schizophrenia (Carter et al., 2008;Curley & Lewis, 
2012). In sum, a common factor amongst these disorders is some type of deficit in the numerous 
circuits that contribute to proper sensation and perception including the cortico-thalamic circuitry.  
 
1.2 Role of the thalamus in sensory processing  
The thalamus was once thought to simply relay information from the periphery and sub-cortical 
structures to the proper cortical destination has since been expanded upon. Before terminating in 
the cortex, sensory information goes through circuits involving the thalamus such as 
thalamocortical (TC), corticothalamic (CT), thalamo-thalamic circuits. The thalamus is made up 
three functionally distinct types of nuclei: relay nuclei, intralaminar nuclei, and thalamic reticular 
nucleus (TRN) (Veres, Linley, & Hoover, 2015). The relay nuclei represent the majority of 
thalamic nuclei, are comprised of glutamatergic neurons, and are function/modality specific 
(Figure 1). “Relay” refers to nuclei that are passing information between brain regions as opposed 
to being the main drivers themselves or the ultimate destination of information (Crabtree, 2018). 
Depending on the source of their driver input, thalamic relay nuclei are classified as first order 
(FO) or higher order (HO). FO nuclei receive afferents from subcortical and peripheral sensory 
structures (i.e. first in line of the sensory integration process), while HO nuclei receive afferents 
from the cortex, mainly layer 5, and act as a means of communication between cortical areas (Lam 
& Sherman, 2011;Crandall, Cruikshank, & Connors, 2015). The majority of these driver inputs 




reticular formation and are involved in sensory-motor integration (Fisher & Reynolds, 2014). 
Finally, and the main focus of my thesis is the TRN. In the section below, I will describe in detail 
the neurobiology of this nucleus. 
 
 
1.3 Functional organization of the thalamic reticular nucleus and its role in sensory 
processing  
In addition to driver inputs that carry specific information to relay nuclei, FO and HO nuclei 
receive inhibitory and excitatory modulatory afferents that fine tune the information arriving to 
these nuclei before it is relayed further. The excitatory modulator afferents originate from layer 6 
of the cortex, whereas the inhibitory afferents originate from the TRN (Sherman & Guillery, 2002). 
The TRN is the only thalamic nucleus comprised of entirely GABAergic neurons and is crucial in 
controlling the excitation and gain of the thalamocortical transmission (Pinault, 2004). Both 
 
Figure 1. Anatomy of nuclei in the dorsal thalamus. The TRN wraps around FO and HO 
relay nuclei. FO nuclei include the lateral geniculate nucleus (LGN), medial geniculate 
nucleus (MGN), ventroposterolateral nucleus (VPL), ventral lateral nucleus (VL), and 
ventral anterior nucleus (VA). HO nuclei include the medial dorsal nucleus (MD), 





descending afferents from the cortex to the thalamus (corticothalamic or CT) and ascending 
efferents from the relay nuclei to layer 4 of the cortex (thalamocortical or TC) converge on the 
TRN (Figure 2) (Crabtree & Isaac, 2002). This not only allows a way for cortical areas to 
communicate with each other without direct innervation with one another, but also allows the same 
for thalamic nuclei. The relay and interpretation of stimuli can go awry in either the CT or TC 
pathways, but dysfunction in the TRN has the potential to disrupt both of these pathways. Also, 
sensory processing relying on a delicate balance of excitation and inhibition puts a lot of focus on 
the TRN. The importance of the TRN in sensory processes was established long ago when Francis 
Crick said that if the thalamus is the gateway to the cortex then the TRN is considered the guardian 
of that gateway (Crick, 1984).  
As described above, the TRN participates in both feedforward and feedback processing of sensory 
information in the form of LVI → TRN → TC neurons and TC neurons → TRN → TC neurons, 
respectively (Crabtree, 2018). Aside from being the only GABAergic nucleus of the thalamus, the 
TRN also differs from the other nuclei in the sense that it receives afferents from cortical and sub-
cortical structures (so it is neither FO or HO) and only innervates thalamic relay nuclei (Pratt et 
al., 2016). An example of these circuits working together to respond to stimulus is that of a visual 
cue and is shown in Figure 2. The retina sends the visual information to the first-order lateral 
geniculate nucleus (LGN). The LGN is innervated by the TRN and will provide inhibitory 
feedback before the LGN passes this information to the visual cortex. The cortex then sends this 
information back down the higher-order Pulvinar (Pulv) within the thalamus, also innervated by 
the TRN (Pratt et al., 2016). This is of course a simplistic version of the circuit as it ignores other 
sub-cortical modulatory inputs that contribute to determining the significance of the visual 




modalities that are connected to different relay nuclei associated with that sensory modality. In 
particular, the dorsocaudal TRN is the visual sector, ventrocaudal is the auditory sector, 
ventrocentral is the somatosensory sector, and lastly the least studied rostral motor sector 
(Crabtree, 2018). A single TRN neuron can innervate more than one thalamic nucleus, but these 
multiple thalamic nuclei are often functionally related to each other (Pinault & Deschênes, 1998). 
This aspect is particularly important when considering attention to competing stimuli. An example 
is the suppression of the visual TRN (connected to LGN) and activation of the auditory TRN 
(connected to MGN) during a visual task with an auditory distractor (Wimmer et al., 2015).  
Aside from receiving glutamatergic projections from layer 5 of the cortex (Zikopoulis & Barbas, 
2007) and thalamic relay nuclei (Pinault, 2004), the TRN also receives GABAergic signals from 
the lateral hypothalamus to regulate arousal (Hou et al., 2016), the globus pallidus (Gasca-
 
Figure 2. Simplified illustration of thalamocortical and corticothalamic pathways that 
converge on the TRN when processing visual information from the eye. The LGN (FO nucleus) 
receives driver input about visual stimuli from the retina as well as modulatory afferents from 
cortical layer VI and the TRN. The LGN then terminates in cortical layers III and IV. The pulv (HO 
nucleus) receives its driver input from cortical layer IV corresponding to the visual stimuli, as well 
as modulatory afferents from cortical layer VI and the TRN. The pulv then innervates cortical layers 







Martinez et al., 2010), as well as cholinergic inputs from the basal forebrain (Pita-Almenar et al., 
2014), monoamergic and cholinergic afferents from the brain stem (Jones, 1991), and 
dopaminergic afferents from the substantia nigra (Picazo et al., 2009). The amygdala has also been 
shown to project directly to the TRN, with 70% of axons terminating in the rostral TRN, and be 
important for emotional attention in monkeys (Zikopoulis & Barbas, 2012).  
Cortical areas and associated specific relay nuclei corresponding to different somatosensory and 
motor information form a topographic map onto the TRN (Pinault, 2004). Therefore, although FO 
and HO thalamic relay nuclei may not communicate directly, the same sensory input driving them 
will converge and be integrated in the TRN. To make matters even more complicated, the TRN 
and relay nuclei can participate in both open and closed feedback loops. The closed loop consists 
of a thalamic relay neuron projecting onto the TRN and the TRN then sending inhibitory input to 
that thalamic relay neuron. The open loop is when a thalamic relay neuron projects onto the TRN 
and then the TRN sends inhibitory input to a different thalamic relay neuron (Barbas & Zikopoulis, 
2007). Additionally, TRN neurons innervate themselves in what is called lateral inhibition, and 
this is thought to play a significant role in convergent sensory information from different sources 
competing for attention (John et al., 2016). The complex role of the TRN in the integration of 
information that is sent back and forth to the cortex makes this an exciting focus of study. I will 








1.4 The thalamic reticular nucleus in health and disease  
Given the key role of the TRN in the thalamus, it is not surprising that this nucleus has been linked 
to the physiological functions related to sensory processing and to neurological conditions in which 
this sensory processing is altered. The TRN has been reported to play a role in attention (Wells et 
al., 2016; McAlonan et al., 2000;Weese et al., 1999; Zikopoulos & Barbas, 2006;Wimmer et al., 
2015), arousal (Lewis et al., 2015), pain sensitivity (Liu et al. 2017), memory consolidation via 
the induction of sleep spindles (Latchoumane et al. 2017;), cognition and working memory 
(Whissell et al., 2019), and motor processes (Villalobos et al., 2016).  
Dysfunction of the TRN has been observed or strongly implicated to play a role in various 
psychological disorders such ADD and ADHD (McAlonan et al., 2000;Wells et al., 2016), ASD 
(Green et al., 2017;Wells et al., 2016), bipolar disorder (BPD) (Ferrarelli & Tononi, 2017;Steullet 
et al., 2018), and SCZ (Ferrarelli & Tononi, 2017; Baran et al., 2019;Steullet et al., 2018; Young 
& Wimmer, 2017). The TRN’s strategic position between the thalamus and cortex sets it up to be 
a common denominator in these diseases.  
Another characteristic that the disorders mentioned above share is abnormal sleep spindles. Sleep 
spindles are synchronized oscillations in the frequency range of 9-16 Hz that occur in nonrapid 
eye movement (NREM) sleep and are thought to support neuroplasticity and memory 
consolidation (Latchoumane, Ngo, Born, & Shin, 2017). The TRN is well known to be the original 
source of sleep spindles by changing their firing mode to bursts, deinactivating low-threshold 
calcium channels and leading to rebound burst firing that ultimately activates the TRN (Piantoni 
et al., 2016). Spindles can vary across samples in duration, amplitude, and frequency depending 
upon the overall communication of the entire thalamocortical circuit, which then impact waking 




The fact that sleep spindles can easily be measured makes them a promising biomarker for disease. 
Lower sleep spindle intensity and amplitude in adolescents with ASD are associated with severity 
of autistic traits (Merikanto et al., 2019). There are increased slow-spindle activity in children 
diagnosed with ADHD (Saito et al., 2019). Many studies have found impairments in sleep spindle 
density, amplitude, and duration in patients with chronic SCZ (reviewed in Kaskie et al., 2019). 
Interestingly, patients experiencing the first-episode of psychosis, and therefore unmedicated, had 
reduced spindle duration and intensity, but not amplitude (Kaskie et al., 2019). In addition, the 
severity of spindle dysfunction in these first-episode in patients with SCZ predicted the severity 
of the negative symptoms they would go on to form, indicating that quality of sleep spindles is 
present as early as the onset of schizophrenia as opposed to be a product of chronic schizophrenia 
(Kaskie et al., 2019). What exactly initiates these spindle abnormalities in psychiatric disorders is 
unknown. 
 
1.5 Neuronal populations within the thalamic reticular nucleus 
Although all neurons in the TRN are GABAergic, different populations of cells have been 
identified through peptide markers. The majority of neurons express the calcium-binding protein 
parvalbumin (PV+) (Steullet et al., 2018; Alberi et al., 2013). The peptide somatostatin (SST+) and 
calbindin (CB+) are also expressed in cells of the TRN (Pinault, 2004;Martinez-Garcia et al., 2020). 
The neuropeptide cholecystokinin (CCK) was shown to be expressed in the TRN decades ago 
(Sohal, Cox, & Huguenard, 1998), but little research has been done to understand function of cells 
that express CCK (CCK+) in this area of the brain compared to PV+, CB+ and SST+ interneurons.  




considering the individual differences of among them, with emphasis on different firing properties, 
co-expressed receptors, and their ability to modulate one another (Table 1).  
 
The function of CCK+ interneurons within the TRN has not yet been determined. Part of this thesis 
is to lay the groundwork to characterize the role of CCK+ interneurons in the function of the TRN. 
Furthermore, because CCK+ interneurons in other brain areas are hugely enriched with the 
cannabinoid receptor type 1 (CB1R), we also sought to generate preliminary evidence of the 
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. Regular spiking 
. Slow, weak, less precise 
than PV 
. Erbb4 . Inhibit pyramidal 





. Regular Spiking 
. Unknown . Inhibit pyramidal 
neurons typically at 
dendritic sites 
Table 1. Properties of neuronal populations classified according to peptide markers in the 
TRN. Although these interneuron populations are well-defined in other areas of the brain, they 
still remain relatively elusive in the TRN. N-methyl-D-aspartate receptor (NMDA), serotonin 





1.6 Cholecystokinin-expressing interneurons and cannabinoid receptor type 1 in the 
thalamic reticular nucleus 
Endocannabinoids have been linked to the regulation of sleep states (Pava et al., 2014;Perescis et 
al., 2020), pain sensitivity (Smith et al., 2017;Woodhams et al., 2017), anxiety (Smith et al., 
2017;Ruehle et al., 2012; Patel et al., 2017), and memory deficits (Smith et al., 2017; Volk & 
Lewis, 2016). The two main endocannabinoids produced in the brain are anandamide and 2-
arachidonoyl glycerol (Cristino et al., 2020). These endocannabinoids bind to CB1 and CB2 
receptors. The distribution of cannabinoid receptors across brain regions is highly conserved in 
different species (Katona & Freund, 2012), further demonstrating the importance of this system.  
CB1R has previously been shown to be expressed in the TRN (van Rijn et al., 2010), but the cell 
type in which it is expressed has not been determined. In the rest of the brain CB1R is expressed 
primarily on CCK+ interneurons (Katona et al., 1999;Omiya et al., 2015;Neu et al., 2007;Bowers 
et al., 2014). And our lab replicated these results CCK+ interneurons express 100 fold more CB1R 
transcript than pyramidal neurons (Bunda, LaCarubba, Akiki, & Andrade, 2019). Although, PV+ 
interneuron axon terminals have been found to express CB1R in the infralimbic prefrontal cortex 
in small amounts (Liu, Dimidschstein, Fishell, & Carter, 2020) and excitatory terminals of 
pyramidal neurons also express small amounts of CB1R (Liu et al., 2020). Activation of 
CCK/CB1R neurons ultimately leads to suppression of neurotransmitter a process called 
depolarization-induced suppression of inhibition or excitation depending on whether the 
neurotransmitter is GABA or glutamate (DSI and DSE, respectively). Stimulation of the post-
synaptic cell results in synthesis of endocannabinoids that travel back to the CCK/CB1R pre-
synaptic neuron where it binds to CB1R and blocks calcium channels needed for neurotransmitter 




1.7 Function of cholecystokinin-expressing interneurons in other areas of the brain  
CCK+ interneurons have been widely studied in other areas of the brain, thus we can gain insight 
about their function by reviewing the information about these neurons from other areas such as the 
amygdala and hippocampus. In contrast to PV+ interneurons, CCK+ interneurons display regular-
spiking activity and asynchronous release of GABA via N-type calcium channels, leading to long-
lasting inhibition (Hefft and Jonas, 2005). Activation of CCK+ interneurons in the mouse brain 
results in enhanced memory and cognition with no effect on emotional processing (Whissell et al., 
2019). A more region-specific activation of this same interneuron population within the basal 
amygdala (BA) leads to modulation of fear extinction (Rovira-Esteban et al., 2019). CCK+ 
interneurons within the hippocampus express vasoactive intestinal polypeptide (VIP), vesicular 
glutamate transporter type 3 (VGLUT3), somatic GABAB receptors, and 5-HT3 receptors (Freund, 
2003). Furthermore, CCK+ interneurons in hippocampus and amygdala are enriched with large 
amounts of the cannabinoid receptor 1 (CB1R) (Bowers & Ressler, 2014; Iball & Ali, 2011; 
Katona et al., 1999; Lee, Földy, & Soltesz, 2010). Roughly 90% of CB1R expressing interneurons 










2.0 RESEARCH QUESTIONS 
In this thesis, I performed a thorough histochemical characterization of genetically identified CCK 
interneurons in the TRN. To do this, we labeled CCK interneurons using intersectional labeling 
(Figure 3). An intersectional approach was necessary because the CCK promoter is active in both 
excitatory and inhibitory neurons. In order to restrict the expression of the red fluorescence protein, 
tdTomato (tdT) to CCK expressing interneurons we took advantage of the activity of the distal-
less homeobox 5/6 (Dlx5/6) promoter, which is specific of forebrain interneurons. In this approach, 
two recombinases (Cre and Flpe) which expression depends on the CCK and Dlx5/6 promoters 
respectively, excise two stop codons present before the start site of tdT. Thus, it is condition that 
both promoters are active in the same cell to induce the expression of tdT (Taniguchi et al., 2011). 
I will hereafter name this novel cell population as CCK;Dlx5/6 neurons.  
I pursued the following research questions: Are CCK;Dlx5/6 cells in the TRN neurons? How are 
CCK;Dlx5/6 neurons distributed across the anatomical regions of the TRN? Do CCK;Dlx5/6 
neurons express the CCK peptide? Do CCK;Dlx5/6 neurons express the PV peptide? Do 
CCK;Dlx5/6 neurons express CB1R similar to what has been observed in this neuronal type in the 
amygdala and hippocampus? What are the likely synaptic targets of CCK;Dlx5/6 interneurons? 
We expect that by answering these questions, we provide insights into the role of this novel cell-










All procedures were approved by the Institutional Animal Care and Use Committee at the 
University of New Hampshire (APPENDIX). To label CCK;Dlx5/6 neurons in the TRN, we 
performed intersectional labeling. We obtained a triple transgenic mouse line containing alleles 
for CCK-Cre, Dlx5/6-Flpe and tdT via breeding (Figure 3). Initially, Cck-Cre mice (012706; The 
Jackson Laboratory) were crossed with Dlx5/6-Flpe mice (010815; The Jackson Laboratory). Cre 
and Flpe are recombinases expressed under the control of the CCK promoter and the Dlx5/6 
promoter, respectively. Progeny from this initial cross, Cck-Cre; Dlx5/6-Flpe (abbreviated CCK-
Dlx5/6), were dual transgenic mice with both alleles. Because mice with the Dlx5/6 alleles could 
 
Figure 3. Breeding scheme to label CCK;Dlx5/6 cells in 
the TRN. Top panel: homozygous CCK-IRES-cre mice are 
first mated with Dlx5/6;Flpe mice. Middle panel: The 
offspring of this mating produce CCK;Dlx5/6 mice, which 
are then mated with tdT homozygous mice to produce 
CCK;Dlx5/6;tdT progeny. Recombination of Cre-loxP and 
Flpe-FRT remove both STOP cassettes and result in tdT 




not be bread to homozygosity, we selected for CCK-Dlx5/6 mice that were homozygous for CCK-
Cre and heterozygous for Dlx5/6-Flpe. To optimize the recombination efficiency, male CCK-
Dlx5/6 mice were bred to female mice containing a tdT allele downstream of two recombinase 
target-flanked STOP cassettes (Ai65(RCFL-tdT)-D;021875; The Jackson Laboratory). The first 
STOP cassette was flanked by loxP sites (recognized by Cre) and the second was flanked by FRT 
sites (recognized by Flpe) (Figure 3). The resulting progeny had individuals with two distinct 
genotypes: A) heterozygous for CCK-Cre and Ai65(RCFL-tdT)-D, but WT for Dlx5/6-Flpe, and 
B) heterozygous for the three alleles (abbreviated CCK;Dlx5/6;tdT). In the latter mice, Cre-Lox 
and Flpe-FRT recombination removed the two STOP cassettes, resulting in tdT fluorescence in 
cells that expressed both CCK and Dlx5/6. 
 
3.2 Genotyping 
To differentiate between mice with genotype A and genotype B, we performed three PCR reactions 
in genomic DNA. This was an extensive amount of work because entire litters needed to be 
genotyped to select individuals with proper tdT expression. Briefly, genomic DNA was extracted 
from P7-P9 animal tissue using Phire Animal Tissue Direct kit II (ThermoFisher Scientific, 
F140WH) according to manufacturer instructions. PCR was performed with AmpliTaq Gold® 360 
mastermix (Thermo Fisher Scientific, 4398881) using the following conditions: a hot start of 950 
C for 10 min, followed by 35 cycles (950 C, 30 s; 600 C, 30 s; 720 C, 1 min), and a final step of 720 
C for 7 min. Primers and expected products are shown in Table 2. Primers were added to the same 
mixture for genotyping. Figure 4 shows typical PCR for mice with genotype A (lanes 1, 3, and 5), 
and genotype B (lanes 2, 4, and 6). Note the presence of ~ 400 bp band in lane 2 that correspond 







Primers Expected products 
CCK-Cre F-WT1: GGGAGGCAGATAGGATCACA 
F-MT1: TGGTTTGTCCAAACTCATCAA  
R: GAGGGGTCGTATGTGTGGTT 
Hom: 180 bp 
Het: 180 bp and 468 bp 
WT: 468 bp 
Dlx5/6-Flpe F-T1: CAGAATTGATCCTGGGGAGCTACG 
R-T1: CCAGGACCTTAGGTGGTGTTTTAC 
F-C: CAAATGTTGCTTGTCTGGTG 
R-C: GTCAGTCGAGTGCACAGT TT 
Transgene: 406 bp 
PCR positive control: 
200 bp 






F-WT2: AAGGGAGCTGCAGTGGAG TA 
R-WT2: CCGAAAATCTGTGGGAAG TC 
R-MT1: GGCATTAAAGCAGCGTAT CC 
F-MT2: CTGTTCCTGTACGGCATGG 
Hom: 196 
Het: 196 and 297 
WT: 297 







Figure 4. PCR results from CCK;Dlx5/6;tdT mice. Mouse A genotype regarding each gene is 
found in lanes 1 (200 bp), 3 (180 and 468 bp), and 5( 196 and 297 bp). This indicates that mouse 
A is Dlx5/6-Flpe -/-, CCK-Cre +/-, tdT +/-. Mouse B genotype can be found in lanes 2 (200 and 
406 bp), 4 (180 and 468 bp), and 6 (196 and 297 bp). In contrast to mouse A, mouse B contains the 
transgene for Dlx5/6-Flpe in lane 2 at 406 bp, and therefore is Dlx5/6-Flpe +/-.  





Adult CCK;Dlx5/6;tdT mice of both sexes were deeply anesthetized in a chamber of isoflurane 
(07-893-1389; Patterson Veterinary). After ensuring the absence of rear-foot reflex, an 
intraperitoneal injection of 0.07 mL Euthasol® euthanasia solution (Virbac Animal Health, Co) 
was given in the lower right abdomen with a 26-gauge needle. I next performed cardiac perfusion 
with ice cold 1X PBS (1002657611; Sigma Aldrich), followed by ice cold 4% formalin solution 
(HT501128; Sigma Aldrich), and followed again by ice cold PBS. The brains were then extracted 
and stored in 4% formalin solution at 4˚ C for 24-48 hours. 50 µm coronal slices were prepared 
using a vibratome (VT1000S; Leica) between -0.5 mm and -1.9 mm relative to Bregma to ensure 
the entirety of the TRN was included. The slices were then kept in 12 well plates containing 1X 
PBS and stored at 4˚ C overnight. The following day, slices were rinsed with PBS 3 times for 10 
minutes while rotating (Roto Mix Type 50800; Thermolyne) to ensure removal of formalin 
solution. 
For CCK, PV and NeuN staining: Slices were then incubated in a blocking buffer consisting of 
0.2% Triton-X (1002214179; Sigma Aldrich) in 1X PBS, 10% normal goat serum (ab7481; 
Abcam), and 10% BSA (A9418; Sigma Aldrich) for 30-60 minutes while lightly rotating. The 
slices were then rinsed with PBS for 10 minutes while rotating 3 times. The primary antibodies 
rabbit polyclonal anti-CCK-8 (C2581; Sigma Aldrich), rabbit polyclonal anti-PV (ab11427; 
Abcam), and/or mouse monoclonal anti-NeuN (MAB377; Sigma Aldrich) were added to the slices 
sitting in blocking buffer mentioned above at a concentration of 1:1000. For CB1R staining, 
permeabilization detergents were not used: slices were incubated in a blocking buffer that 




containing the primary antibody extracellular rabbit polyclonal anti-CB1R (ACR-001; Alomone 
labs) at 1:1000.  
Slices were covered and left in 4˚C for 18-24 hours while rotating. The slices were then rinsed 
again in PBS 3X, while lightly rotating, before adding the secondary antibodies Alexa488 
(ab150077; Abcam) for rabbit primary antibodies, Alexa647 (ab150115; Abcam) for mouse 
primary antibodies, and/or FITC (ab97239; Abcam) for mouse primary antibodies at a 
concentration of 1:1000 in PBS to incubate for 2 hours in the dark, at room temperature, while 
rotating. Slices were then rinsed again with PBS before adding the nuclear stain To-Pro-3 iodide 
(T3605; inVitrogen) or SYTO-13 (S7575; Thermofisher) at a concentration of 1:1000 in PBS for 
20 mins at room temperature. Slices were then rinsed another 3 times with PBS in the dark, while 
rotating before being mounted on to positively charged glass slides(1358W; Globe Scientific) with 
Vectashield hard set mounting medium (H-1400; Vector Labs) and micro glass cover slips(48393; 
VWR). Slides were allowed to dry before sealing with clear nail polish.  
To visualize the red fluorescence from tdT in the CCK;Dlx5/6 neurons and green fluorescence 
from antibodies against the proteins mentioned above, a Nikon A1R laser-scanning confocal 
fluorescence microscope was used. Fluorophores and their spectra were as follows 
(excitation/emission (nm)): tdTomato (554/581), Alexa 488 (495/519), FITC (493/528), Alexa 647 
(652/668), SYTO-13 (488/509, and TO-PRO-3 (642/661). Slices were never co-stained with 
fluorescent proteins that had significant overlapping emission spectra. Images were taken at 10X 
to view the TRN in its entirety, 20X to visualize individual tdT+ cells in the TRN. Brain slices with 
multiple fluorescent proteins with overlapping wavelengths were scanned and imaged using a 




both TRNs per brain slice were taken, often in the form of 10X z stacks at slice thickness ranging 
from 2 µm to 4 µm.  
Confocal images were originally saved in .ND2 format on to a flash drive and later opened with 
ImageJ Fiji for analysis. Cell counts were done manually using the Cell Counter plug in for FIJI 
(https://imagej.nih.gov/ij/plugins/cell-counter.html). Cell counts were done for tdT+ cells 
(CCK;Dlx5/6 neurons) within the TRN, and tdT+ cells that colocalized with the proteins of interest 
(NeuN, PV, CCK, and CB1R). Colocalization of 2 different fluorescent proteins was also done 
manually. To keep consistency across brain slices and individual mice, cell counts were done on 
the max intensity projection of the Z stack collected. This combines all individual pictures taken 
within the z stack to give a better representation of fluorescence throughout the entire slice.  
To image larger brain regions when analyzing potential target areas of TRN CCK;Dlx5/6 neurons 
throughout the thalamus, variations in surface focal point across the slice were adjusted 
accordingly using the NIS software before scanning the whole image, with each picture sized at 
1024. Individual z stacks taken at each focal point were then stitched together with 10 % overlap. 
We measured corrected total area fluorescence (CACF) associated to different thalamic nuclei. 
Areas that correspond to thalamic nuclei were drawn based on the Allen Brain Reference Atlas for 
the adult mouse (Lein et al., 2007). All areas were drawn relative to the localization of the TRN, 
which was easily distinguishable thanks to the strong tdT signal from CCK;Dlx5/6 neurons. CACF 
was corrected for background fluorescence. CACF was calculated with the following formula: 
CACF = Integrated Density – (Area x mean fluorescence of background). Integrated density is the 





The tdT fluorescence signal in all of our images was pseudcolored with magenta instead of red to 
facilitate the interpretation of our results by people with color blindness. 
 
3.4 Statistical analysis 
Cell counts of tdT-expressing cells of the TRN manually counted using the ImageJ FIJI Cell 
Counter Plugin were collected for every individual slice. To determine if tdT+ cells of the TRN 
co-expressed any of the proteins of interest (NeuN, PV, CB1R, and CCK), the different channels 
were merged with the tdT images for each slice and the cells that appeared to show co-localization, 
often producing a yellow color as a result of red tdT and green secondary antibody of protein of 
interest. The number of cells counted as expressing both tdT and the secondary antibody were then 
divided by the total number of tdT cells to give an average of co-localization. If a mouse had 
multiple brain slices stained and imaged, those averages would then be combined to give an overall 
average of co-localization for that individual mouse. Averages and S.E.M. were calculated using 












4.1 Novel CCK;Dlx5/6 neurons identified in the TRN 
Previous studies have shown the presence of mRNA for CCK in neurons as well as non-neuronal 
tissue (Hökfelt T et al., 1991). Furthermore, some promoters can exhibit basal activity regardless 
of the presence of their transcription factors leading to low unregulated gene expression (Bittner-
Eddy, Fischer, & Costalonga, 2019), Because in the CCK;Dlx5/6;tdT mouse line we are utilizing 
two promoters to label CCK;Dlx5/6 neurons, thereby increasing the possibility of finding 
expression of tdT in non-neuronal tissue. To rule out this possibility, we first confirmed that 
CCK;Dlx5/6 cells in the TRN are indeed neurons. We stained slices of CCK;Dlx5/6;tdT mice with 
the neuronal marker NeuN. Next, we quantified the number of cells exhibiting fluorescent signals 
for tdT and NeuN. We found that approximately 94.4% of tdT cells also express NeuN (mean ± 
s.e.m. = 94.5 ± 1.06 %, n = 4, 2-4 slices per mouse. Figure 5A and 5B). No differences were 
observed between males and females, and the tdT in the TRN labeling was consistent among 
multiple litters and generations. This result strongly suggests that the vast majority of CCK;Dlx5/6 
 
Figure 5. Staining of CCK;Dlx5/6;tdT slices with NeuN identifies tdT+ cells within the TRN as 
neurons. A. 10x confocal images of the TRN. Left, tdT in the TRN (magenta); Middle, NeuN 
expression (green); Right, tdT and NeuN merged. Scale = 200 m. B. On average, 94.4% of 
CCK;Dlx5/6 neurons in the TRN are positive for expression of NeuN across all samples. Data are 





























cells in the TRN are neurons. Furthermore, our images show that CCK;Dlx5/6 neurons are 
strikingly localized to the TRN because none of the cell bodies for these neurons was observed in 
none of the relay or intralaminar nuclei (Figure 5A). Our results unveiled a novel neuronal 
population that has not been characterized before in the TRN and that is distinguished with the 
activity of CCK and Dlx5/6 promoters. 
 
4.2 Distribution of the CCK;Dlx5/6 neurons in the TRN 
As indicated above, the TRN is subdivided into three regions in head, body and tail (Perez et al., 
2017). Interestingly, head is associated to the processing of visual information, whereas cells in 
the body process somatosensory information, and the tail motor information (Pinault & Deschênes, 
1998). To gain insights into the potential function of CCK;Dlx5/6 neurons in the TRN we 
determined their relative abundance in each of the three regions. To determine the relative 
 
Figure 6. Relative distribution of CCK;Dlx5/6 neurons across the head, body, and tail regions 
of the TRN. A. 10x confocal images of the TRN with the head, body, and tail regions segregated. 
Left, tdT expression in the TRN (magenta). Middle, NeuN expression (green) across regions and the 
dorsal thalamus. Right, tdT and NeuN expression merged. Scale = 200 m. B. Quantification of 
CCK;Dlx5/6 neurons of the TRN across regions reveal that approximately 27.7% in the head, 18.6% 
in the body, and 12.1% in the tail of NeuN+ neurons in the TRN express tdT, with the head region 
having the highest concentration. Data are represented using a box plot with interquartile range and 


































distribution of CCK;Dlx5/6 neurons , the TRN was separated into 3 regions: head, body, and tail 
(Figure 6A). All confocal images used for data analysis were in the form of a single image that 
combined every image within the z-stack for that given slice. By doing this, we disregarded 
differences in distribution in terms of rostral vs caudal as some previous studies have done. We 
quantified the amount of cells with signals for tdT and NeuN relative to the total number of NeuN+ 
neurons throughout the TRN in each region (Figure 6A). 
 
Approximately 27.7 % of neurons within the head region express tdT, 18.6% of neurons in the 
body express tdT, and 12.1% of neurons in the tail express tdT (% of CCK;Dlx5/6 neurons per 
TRN region, mean ± s.e.m. head = 27.7 ± 3.0 %, body = 18.6 ± 1.3 %, tail = 12.1 ± 1.1 %. Figure 
6B). Three individual t tests were run to compare concentration of neurons between the 3 regions. 
The t test comparing the head and body region was p = 0.044, for the head and tail region was p = 
0.0055, and body and tail was p = 0.0044. To correct for multiple comparisons, I used the 
 
Figure 7. Distribution of CCK;Dlx5/6 neurons in regions of the TRN per mouse. Comparison 
of the relative proportion of CCK;Dlx5/6 neurons per region among individual mice. At least 3 
slices per mouse were analyzed. Data are represented using a box plot with interquartile range 





























Bonferroni correction and  was set at 0.016, thus all p values below 0.016 were considered 
significant. The relative abundance of CCK;Dlx5/6 neurons was higher in the head than tail and 
the body relative to the tail (Figure 6B). These results show that there is pattern of distribution of 
CCK;Dlx5/6 neurons, where there is higher abundance of them in the dorsal region (head) relative 


























4.3 CCK;Dlx5/6 neurons in the TRN express the CCK peptide 
The DNA recombination and thus tdT expression by Cre and Flpe recombinases is irreversible, 
this opens the possibility that a transient expression of either or the two enzymes resulted in the 
production of tdT at some point in development, without necessarily labeling neurons that express 
the CCK peptide (Abremski & Hoess, 1984;Metzger & Feil, 1999). To rule out this possibility, we 
 
 
Figure 8. Expression of CCK peptide in CCK;Dlx5/6 neurons of the TRN. A. 10x 
confocal images of coronal slices of the TRN. Left, tdT in the TRN (magenta); Middle, 
CCK peptide expression (green); Right, tdT and CCK peptide merged. B. Quantification 
CCK;Dlx5/6 neurons expressing CCK peptide in the TRN. Scale = 200 m. C. 
Percentage of CCK;Dlx5/6 neurons in the TRN positive for expression of CCK peptide 
is consistent across mice. Data are represented using a box plot with interquartile range 
and 95% confidence interval. Outliers were calculated as Q1 – (1.5 X IQR) and Q3 + 


















































































performed immunohistochemistry experiments using an antibody against CCK. This experiment 
is essential to provide a thorough characterization of the CCK;Dlx5/6 neurons in the TRN. Brain 
slices from CCK;Dlx5/6;tdT mice were stained for the CCK peptide. We found that approximately 
98.5% of CCK;Dlx5/6 neurons within the TRN expressed the CCK peptide (% of CCK;Dlx5/6 
expressing CCK, mean ± s.e.m. = 98.5 ± 0.4%, n = 6 mice, 3-5 slices per mouse. Figure 8A-B). 
This observation was also consistent across different mice (Figure 8C). We observed wide 
expression of CCK in the TRN and thalamus, which is not surprising given that CCK is the most 
abundant neuropeptide in the brain (Figure 8A). Our results strongly suggest that CCK;Dlx5/6 
neurons in the TRN belong to a class of interneurons that express the CCK peptide in adulthood 
and our intersectional strategy to label them is adequate. 
 
4.4 CCK;Dlx5/6 neurons in the TRN partially express parvalbumin 
As noted previously, it has been suggested that all neurons within the TRN expresses PV (Hou, 
Smith, & Zhang, 2016). Although recent evidence suggests that there is another non-overlapping 
population of interneurons expressing SST in the TRN (Perez et al., 2017). In the hippocampus 
CCK+ and PV+ interneurons represent two non-overlapping classes of interneurons (Hefft & Jonas, 
2005). Therefore, we tested if CCK;Dlx5/6 express PV in the TRN. We stained for PV using 
antibodies against this protein. We found that approximately 58 % of CCK;Dlx5/6 neurons in the 
TRN also express PV (% of CCK;Dlx5/6 neurons expressing PV, mean ± s.e.m. = 58.1 ± 5.7 %, n 
= 4. Figure 9A and B).  However, this observation was not consistent among different mice 
(Figure 9C). Our results suggest that in terms of PV expression, there are two subpopulations of 









Figure 9. Expression of the PV peptide in CCK;Dlx5/6 neurons in the TRN. A. 10x confocal 
images of the TRN. Left, tdT expression (magenta) in CCK/Dlx5/6 neurons. Middle, PV protein 
(green) expression in the TRN and dorsal thalamus. Right, tdT and PV protein staining merged. B. 
Approximately 58% of CCK;Dlx5/6 neurons in the TRN express the PV peptide when averaged 
across 4 mice. Scale = 200 m. C. The percentage of CCK;Dlx5/6 neurons that also express PV 
varied across mice. Data are represented using a box plot with interquartile range and 95% 















































































4.5 CCK;Dlx5/6 neurons in the TRN express the cannabinoid receptor type 1 
CCK+ interneurons from the hippocampus and amygdala have been shown to be enriched with 
CB1R (Bowers & Ressler, 2014; Iball & Ali, 2011; Katona et al., 1999; Lee et al., 2010). Our 
 
 
Figure 10. Expression of CB1R in CCK;Dlx5/6 neurons of the TRN. A. 10x confocal images of 
the TRN. Left, tdT (magenta) expression in CCK;Dlx5/6 neurons. Middle, CB1R (green) protein 
staining. Right, CB1R expression merged with tdT expression. B. Approximately 98.8% of 
CCK;Dlx5/6 neurons in the TRN express the CB1R protein averaged from 5 mice. Scale = 200 m. 
C. Percentage of tdtom neurons in the TRN that express CB1R showed little variability between 5 
mice. Data are represented using a box plot with interquartile range and 95% confidence interval. 
























































































laboratory confirmed these results in the CCK;Dlx5/6 mice using fluorescence activated cell-
sorting coupled to qRT-PCR (Bunda et al., 2019). Thus, we tested if CCK;Dlx5/6 neurons also 
express CB1R in the TRN by staining for the CB1R. We found that approximately 98.8% of 
CCK;Dlx5/6 neurons also express CB1R (% of CCK;Dlx5/6 neurons expressing CB1R, mean ± 
s.e.m = 98.8 ± 0.19, n = 5 mice, 3-5 slices per mouse. Figure 10A and B). Furthermore, this 
observation was consistent across different mice (Figure 10C). Our results suggest that similar to 
CCK+ interneurons from other areas of the brain, CCK;Dlx5/6 also express the CB1R.  
 
4.6 CCK;Dlx5/6 neurons target multiple areas of the thalamus 
To start elucidating the potential target areas of the CCK;Dlx5/6 neurons in the TRN, we took 
advantage of the ability of tdT to travel to via axons to the synaptic terminals(Besser et al., 2015; 
Fujita, Nakanishi, Ueno, Itohara, & Yamashita, 2020; Kim et al., 2020), as well as from previous 
knowledge showing that TRN is the only thalamic nuclei that does not project outside of the 
thalamus (Pinault, 2004). Next, using as reference the Adult Mouse Brain Atlas from the Allen 
Institute (Lein et al, 2007), we estimated the subdivisions of the thalamus and the approximate 
position of each area relative to the TRN (Figure 11A and B). We readily identified the following 
nuclei: medial habenula (MH), lateral habenula (LH) (Figure 11C),  lateral dorsal (LD) (Figure 
11D), mediodorsal (MD) and paracentral (PCN) (Figure 11E), ventral posterolateral (VPL) and 
ventral posteromedial (VPM) (Figure 11F), ventral anterior-lateral (VAL), ventral medial (VM) 
and submedial nucleus (SMT) (Figure 11G), and the posterior complex (PO) (Figure 11H). Next, 
we quantified the fluorescence in each of these putative regions of the thalamus. It is important to 




not ideal to determine synaptic targets, this represents a first step to assess the thalamic areas that 






Figure 11. Target thalamic areas of CCK;Dlx5/6 neurons. A. Confocal image of the TRN and 
adjacent relay nuclei outlined from CCK;Dlx5/6 slices. B. A visual representation of the thalamic 
nuclei seen in A., according to Allen Brain Atlas C. Relatively small amount of tdT seen in the 
medial habenula (MH) and lateral habenula (LH) D. tdT appears to be highly expressed in the 
laterodorsal nucleus (LD) E. tdT expression in the mediodorsal (MD) and paracentral nucleus 
(PCN) F. Abundant tdT axons expressed in both the ventral posterolateral (VPL) and ventral 
posteromedial nucleus (VPM) G. tdT expression in the ventral anterior-lateral (VAL), ventral 










We found that thalamic areas with the highest fluorescence corrected by background were the LD, 
VPL, and VPM, whereas MD, VM, SMT and CL showed less fluorescence (Figure 12). These 
preliminary observations suggest that CCK;Dlx5/6 neurons are more likely to expand their axons 
and terminals to dorsal and ventral posterior areas rather than medial and ventral medial areas. 
Finally, a high magnification in the LD of brain slices stained with SYTO-13 (a cell body marker) 
shows that CCK;Dlx5/6 neurons form perisomatic synapses around target neurons (Figure 13, 
insets). This is in accordance with previous studies of CCK interneurons from the hippocampus 
 
Figure 12. Fluorescence corrected by background in different thalamic areas. Quantitative 
data of tdT axons and synaptic terminals expressed as fluorescence are presented as mean and s.e.m. 











and amygdala. However, our current analysis does not allow to discard the possibility that these 







Figure 13. High magnification image of the LD in slices of CCK;Dlx5/6;tdT mice. Several 
insets were digitally magnified to observe putative synaptic buttons (magenta) around cell bodies 
(green) of target cells located in the LD. Axons are clearly seen in the non-digitally magnified 
image (top left panel, 60X). A-C: White arrows point at putative synaptic buttons, characterized 












An easy way to drive home the function of TRN in sensory processing is referring to research that 
has completely removed it from the brain. However, this does not tell the whole story and isn’t 
quite applicable to sensory disorders in humans where the TRN is never completely absent. 
Removing the TRN and therefore removing this inhibitory feedback and integration of signals is 
not nearly the same thing as the TRN being present but integrating signals in the wrong way. It 
needs to be remembered that the TRN is right in the middle of this bigger circuit where multiple 
parts are contributing to it working properly. For example, if the cortical neurons/driver inputs are 
dysfunctional, do we know that the TRN is able to compensate for this? It is manipulation of 
specific cell types, gene expression, neurotransmitters/neuromodulators that give us the best 
insight.  
My results show that more than a quarter of neurons in the TRN that are part of the head and tail 
are CCK;Dlx5/6 neurons. The head and body of the TRN are two regions associated with 
processing of visual and somatosensory information, respectively (Clemente-Perez et al., 2017; 
Crabtree, 2018; Pinault & Deschênes, 1998). This opens the possibility that CCK;Dlx5/6 neurons 
in the TRN fine tune visual and somatosensory information on its way or back from the cortex.  
My immunohistochemistry analysis for the PV staining in brain slices from CCK;Dlx5/6;tdT mice 
show two CCK;Dlx5/6 population one expressing PV and another without the PV peptide. This 
potential difference could arise from incomplete staining with the PV antibody. Previous reports 
have shown that more than 95% of the TRN neurons express PV, however this may heavily depend 
on the antibody and incubation conditions. We utilized a shorter incubation time than previously 
reported, thus it is possible that our staining conditions did not capture CCK;Dlx5/6 neurons with 




My results also show that almost all CCK;Dlx5/6 neurons express the CCK peptide. This is 
important because suggest that the labeling of these neurons by tdT reflects the adult phenotype of 
CCK;Dlx5/6 neurons and is not the result of transient expression of Cre and Flpe recombinases 
during development. The CCK peptide within itself is an exciting peptide to study because it has 
been implicated in anxiety(Bowers, Choi, & Ressler, 2012; Keimpema, Straiker, Mackie, Harkany, 
& Hjerling-Leffler, 2012; Lach, Schellekens, Dinan, & Cryan, 2018) and manic-like 
behaviors(Arey et al., 2014). However, its role in the thalamus has not been previously described 
and the mechanisms of release for CCK from CCK;Dlx5/6 neurons is not known.  
Exogenous cannabinoids in humans cause symptoms such as hypersensitivity to visual and 
auditory stimuli sometimes leading to hallucinations, reduced working memory, trouble 
coordinating movements, impulsivity, difficulty concentrating, altered sense of time, and general 
changes in mood (NIDA, 2019). As my results indicate, almost all CCK;Dlx5/6 neurons in the 
TRN also express the CB1R. This can be significant to explain the enhanced sensitivity to sensory 
cues induced by cannabinoids. The activation of CB1R inhibits release of neurotransmitters 
including GABA, thus it is predicted that CB1R agonists such cannabinoids would suppress 
CCK;Dlx5/6 neurons leading to disinhibition (lack of filtering) of sensory information traveling to 
and back from the cortex.  
Interestingly, our preliminary evidence shows that cells in the LD receive perisomatic connections 
from CCK;Dlx5/6 neurons, likely from the head. The LD is a HO thalamic nucleus that process 
sensory information arriving from the visual cortex, this nucleus also sends connections to the 
limbic system (Aggleton, Saunders, Wright, & Vann, 2014; Perry & Mitchell, 2019). It is thought 
that the LD is involved in assessing the emotional component of visual stimuli, mainly aversive 




2007). This observation allows to formulate the idea that CCK;Dlx5/6 neurons are finetuning 
emotional responses to sensory cues. However, behavior studies to target CCK;Dlx5/6 neurons 
connecting to the LD will be necessary to determine their role in visual processing. Furthermore, 
our initial evidence also showed that CCK;Dlx5/6 connects to the VPL and VPM, both nuclei relay 
somatosensory information including nociceptive information. The VPL relays spinothalamic 
connections, whereas the VPM receives trigeminothalamic inputs. Thus, it is possible that 
CCK;Dlx5/6 neurons in the TRN are also linked to processing of pain at the central level (Andrew, 
May, & Warren, 2020; Youssef et al., 2019). Interestingly, CCK interneurons in the hippocampus 
and cortex have been linked to emotional processing, and CCK interneurons in the spinal cord 
have been linked to nociception(Bowers & Ressler, 2015; Brown et al., 2014; Truitt, Johnson, 














6.0 FUTURE DIRECTIONS 
6.1 What are the electrophysiological properties of CCK;Dlx5/6 neurons in the TRN?  
To better understand the function of these neurons within the TRN, we need to determine their 
electrophysiological properties. This is particularly important for this area of the brain where the 
other 2 major cell populations in the TRN, PV and SST, have been described as having firing 
properties that are either fast-spiking or regular spiking and typically synchronous release of NT. 
CCK;Dlx5/6 neurons in other areas of the brain appear to be regular-spiking with asynchronous 
release of NT, which is thought to create long-lasting inhibition onto post-synaptic targets. The 
TRN controls activity of the relay thalamic nuclei in part by switching between tonic and burst 
firing and therefore these CCK;Dlx5/6 neurons may play an important in this process that is not 
accomplished by other cell populations previously established in the TRN.  
 
6.2 What are the synaptic properties of CCK;Dlx5/6 neurons in the TRN?  
CCK neurons in other areas of the brain have been shown to release NT in an asynchronous 
manner, which leads to long-lasting inhibition. This feature of this cell type could help us 
understand the impact of these neurons within the TRN onto post-synaptic targets. Other synaptic 
properties to explore could be number of the number of release sites. In other areas of the brain, 
CCK neurons are also shown to rely on N-type calcium channels as opposed to P/Q-type channels 
that PV neurons rely on to release NT. We could stain CCK;Dlx5/6;Tdt brain slices with a marker 
for axonal terminals. Relative distribution and concentration of these terminals in specific areas 





6.3 What neurons do CCK;Dlx5/6 neurons in the TRN target?  
Identifying post-synaptic target sites of these neurons will provide an important missing piece to 
the puzzle, especially when sectors of the TRN correspond to specific functional modalities and 
the relay nuclei that they target are also specific and functionally distinct from one another. It has 
been established that individual TRN neurons that target more than one relay nuclei are targeting 
areas that are associated with the same modality. Exploring if CCK;Dlx5/6 neurons of the TRN 
target other TRN neurons would also give us insight into how intra-TRN activity affects the output 
of these neurons. To accomplish establishing these post-synaptic targets, it may be necessary to 
develop an anterograde tracer capable of specifically targeting CCK;Dlx5/6 neurons of the TRN.  
 
6.4 What behaviors are under the control of or are influenced by CCK;Dlx5/6 neurons in the 
TRN? 
Once electrophysiological and synaptic properties of these neurons, as well as their post-synaptic 
targets are established, it will be easier to speculate what behaviors they may be specifically 
controlling and allow for the design of relevant behavioral experiments. For example, if these 
neurons preferentially target the LD of the thalamus that has been suggested to play a role in limbic 
function, it would make sense to design an experiment that confirm what this means on a 
behavioral level. Ways to accomplish that may be to have mice participate in a task that involves 
the proper recognition of stimuli that is novel vs something that has been conditioned to induce an 
emotional response (or some other task associated with LD function), such as fear. Then by 
selectively activating or silencing CCK;Dlx5/6 neurons of the TRN and having these mice once 




Although PV interneurons of the TRN are thought to drive spindles during NREM sleep 
(Thankachan et al., 2019), the activity of CCK;Dlx5/6 neurons on PV+ neurons should be 
considered. Release of CCK from CCK+ neurons preferentially target PV neurons, leading to 
inhibition of PV neurons. The delicate balance between tonic and burst firing is required for 
spindles, as is synchronous oscillations. It could be hypothesized that in order for PV neurons to 
maintain spindles, CCK;Dlx5/6 neurons would need to be inhibited somehow- leading to 
disinhibition of TRN PV neurons.  
 
6.5 How do CCK;Dlx5/6 neurons interact with cannabinoids to control TRN’s interaction 
with relay thalamic nuclei?  
It has been well established that CB1R and cannabinoids play a significant role in behaviors such 
as sleep maintenance, sensory processing, working memory. The effect that cannabinoids have on 
electrophysiological and synaptic processes of CCK;Dlx5/6 neurons of the TRN could first be 
investigated with slice electrophysiology and the application of CB1R antagonists and agonists. 
Once the impact of cannabinoids on these electrical properties is determined, it could then be 
applied at the in vivo level during behavioral tasks that have been established to be related to the 
function of these neurons within the TRN. For example, using the behavioral experiment 
mentioned above, at each stage: no manipulation, silencing, and activating these neurons, 
cannabinoids could be introduced to provide greater detail into how this cell population is 
coordinating with cannabinoids to control output and subsequently behavior.  
 
6.6 What role do CCK;Dlx5/6 neurons of the TRN play in disease?  
Many diseases that have been shown or suggested to be related to dysfunction of the TRN are 




the behaviors in which they have an influence over have been established, it should be easier to 
narrow down what specific symptoms of these disorders that these neurons may contribute to.  
The next step may be to investigate changes in this cell population within the TRN over 
development, particularly at critical periods involved in the development of spindle activity and 
sensorimotor circuits. This could be done by either evaluating connections of CCK;Dlx5/6 neurons 
onto dorsal thalamic nuclei in post-mortem tissue at different points in development or selectively 
silencing these neurons at different periods in development and observe behavioral phenotypes 
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